CS logo
small CS logo
Zhongda Hospital Southeast University

Nanjing, Jiangsu, China
Hospital in Nanjing
Jiangsu, Nanjing, Gulou, 丁家桥87号 邮政编码 - 210009

About Zhongda Hospital Southeast University


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Southeast University, China
49
Zhongda Hospital
35
Janssen Research & Development, LLC
8
Bayer
6
Jianfeng Xie
6
Eli Lilly and Company
5
Boehringer Ingelheim
4
Harbin Medical University
4
Peking University First Hospital
4
FibroGen
3
Jiangsu HengRui Medicine Co., Ltd.
3
Total Rows: 70

Clinical Trials at Zhongda Hospital Southeast University


During the past decade, Zhongda Hospital Southeast University conducted 160 clinical trials. In the 10-year time frame, 160 clinical trials started and 15 clinical trials were completed, i.e. on average, 9.4% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 10 clinical trials were completed. i.e. 15.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years171713132727181819191919252522221100000044005533Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer
2004-04-01
2006-12-01
Completed
60
A Clinical Trial of IntensiVE Dialysis
2008-05-01
2014-10-01
Completed
200
a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent
2009-12-01
Unknown status
180
Extubation Readiness and Neuroventilatory Efficiency After Acute Respiratory Failure
2008-12-01
2010-07-01
Completed
52
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
2010-04-01
2012-08-01
Terminated
331
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
2010-08-01
2012-12-01
Completed
416
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
2010-12-01
2011-10-01
Unknown status
332
Effect of NAVA on Weaning Duration in Difficult to Wean Patients
2011-09-30
2018-10-01
Completed
99

Rows per page:

1–100 of 204

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Zhongda Hospital Southeast University" #1 sponsor was "Southeast University, China" with 49 trials, followed by "Zhongda Hospital" with 35 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Bayer" with 6 trials sponsored and "Jianfeng Xie" with 6 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 70 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongda Hospital Southeast University" #1 collaborator was "Zhongda Hospital" with 15 trials as a collaborator, "Baxter Healthcare Corporation" with 3 trials as a collaborator, "Guizhou Provincial People's Hospital" with 3 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 3 trials as a collaborator and "The Third Xiangya Hospital of Central South University" with 3 trials as a collaborator. Other collaborators include 137 different institutions and companies that were collaborators in the rest 123 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSoutheast University, China: 49Southeast University, China: 49Zhongda Hospital: 35Zhongda Hospital: 35Janssen Research &Development, LLC: 8Janssen Research &Development, LLC: 8Bayer: 6Bayer: 6Jianfeng Xie: 6Jianfeng Xie: 6Eli Lilly and Company: 5Eli Lilly and Company: 5Boehringer Ingelheim: 4Boehringer Ingelheim: 4Harbin Medical University: 4Harbin Medical University: 4Peking University FirstHospital: 4Peking University FirstHospital: 4FibroGen: 3FibroGen: 3

Created with Highcharts 11.1.0Top CollaboratorsZhongda Hospital: 15Zhongda Hospital: 15Baxter HealthcareCorporation: 3Baxter HealthcareCorporation: 3Guizhou ProvincialPeople's Hospital: 3Guizhou ProvincialPeople's Hospital: 3The First AffiliatedHospital of ZhengzhouUniversity: 3The First AffiliatedHospital of ZhengzhouUniversity: 3The Third XiangyaHospital of CentralSouth University: 3The Third XiangyaHospital of CentralSouth University: 3Affiliated Hospital ofQinghai University: 2Affiliated Hospital ofQinghai University: 2Beijing Shijitan Hospital,Capital MedicalUniversity: 2Beijing Shijitan Hospital,Capital MedicalUniversity: 2Cancer Hospital ofGuangxi MedicalUniversity: 2Cancer Hospital ofGuangxi MedicalUniversity: 2Chinese PLA General Hospital: 2Chinese PLA General Hospital: 2Eli Lilly and Company: 2Eli Lilly and Company: 2

Clinical Trials Conditions at Zhongda Hospital Southeast University


According to Clinical.Site data, the most researched conditions in "Zhongda Hospital Southeast University" are "Septic Shock" (13 trials), "Sepsis" (10 trials), "ARDS" (7 trials), "Coronary Artery Disease" (7 trials) and "Hepatocellular Carcinoma" (7 trials). Many other conditions were trialed in "Zhongda Hospital Southeast University" in a lesser frequency.

Clinical Trials Intervention Types at Zhongda Hospital Southeast University


Most popular intervention types in "Zhongda Hospital Southeast University" are "Drug" (108 trials), "Device" (30 trials), "Other" (19 trials), "Procedure" (18 trials) and "Biological" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (28 trials), "Daratumumab" (4 trials), "FG-4592" (3 trials), "Guselkumab" (3 trials) and "Propofol" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Zhongda Hospital Southeast University


The vast majority of trials in "Zhongda Hospital Southeast University" are 193 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Zhongda Hospital Southeast University


Currently, there are 77 active trials in "Zhongda Hospital Southeast University". 3 are not yet recruiting, 57 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 68 completed trials in Zhongda Hospital Southeast University, 1 suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Zhongda Hospital Southeast University, 8 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 49 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 57Phase 3: 57Not Applicable: 49Not Applicable: 49Phase 2: 28Phase 2: 28Phase 4: 15Phase 4: 15Phase 1: 8Phase 1: 8

Created with Highcharts 11.1.0Trials StatusCompleted: 68Completed: 68Recruiting: 57Recruiting: 57Unknown status: 51Unknown status: 51Active, not recruiting: 16Active, not recruiting: 16Terminated: 6Terminated: 6Not yet recruiting: 3Not yet recruiting: 3Enrolling by invitation: 1Enrolling by invitation: 1Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1